FINANCIAL STATEMENT PICTURES

docx

School

Algonquin College *

*We aren’t endorsed by this school

Course

1200

Subject

Finance

Date

Apr 3, 2024

Type

docx

Pages

7

Uploaded by BailiffFireMonkey29

Report
APPENDICES Key Financial Ratios for Abbott laboratories USA Financial Ratios Current ratio for Abbott laboratories for the fiscal year 2022 is 1.6285. The current ratio of 1.6285 indicates that Abbott Laboratories has $1.6285 in current assets for every $1 in current liabilities. The current ratio of 1.5 to 2 is generally considered healthy, as it indicates that the company has a comfortable cushion of assets to cover short-term debt and therefore Abbott Laboratories sees a strong financial position based on its FY2022 current ratio on. Debt/Equity ratio for Abbott laboratories for the fiscal year 2022 is 0.4545. And Debt/equity ratio for year 2023 is 0.38. The debt/earnings ratio measures the proportion of a company’s finances that comes from debt relative to equity. A ratio of 0.4545 means that for every dollar of equity, Abbott Laboratories USA has $0.4545 of debt. A debt/equity ratio of less than 1 indicates that the firm relies more heavily on equity than debt financing, which may indicate lower financial risk. Generally, a debt/earnings ratio of 0.4545 indicates that Abbott Laboratories USA maintains a prudent balance between debt and equity, allowing for operational flexibility and risk management, at bedtime still uses costs to increase profits. This ratio indicates that the company’s debt level is manageable and not excessive, contributing to a stable financial position.
Balance sheet for Abbott laboratories for seven consecutive years
Summary of the financial data for Abbott laboratories US for the five consecutive years from 2018-2022
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
CONSOLIDATED STATEMENT OF CASH FLOW FOR ABBOTT LABORATORIES FOR THREE CONSECUTIVE YEARS FROM 2020-2022
ACCUMULATED COMPREHENSIVE INCOME (LOSS) FOR ABBOTT LABORATORIES US RETURN ON ASSETS (ROA) FOR ABBOTT LABORATORIES
RETURN ON EQUITY (ROE) FOR ABBOTT LABORATORIES DEBT QUITY FOR ABBOTT LABORATORIES
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
REFERNCES MacroTrends: "Abbott Laboratories Return on Equity (ROE) 2010-2023." MacroTrends. Retrieved from Abbott Laboratories ROE 2010-2023 file:///C:/Users/shubh/OneDrive/Desktop/Abbott%20Laboratories%20ROE %202010-2023%20_%20ABT%20_%20MacroTrends.html SEC EDGAR Database: Abbott Laboratories. (2021). "Form 10-K for the fiscal year ended December 31, 2021." U.S. Securities and Exchange Commission. Retrieved from SEC EDGAR Form 10-K. https://www.sec.gov/Archives/edgar/data/1800/000110465922025141/a bt-20211231x10k.htm YCharts: "Abbott Laboratories Debt to Equity Ratio." YCharts. Retrieved from Abbott Laboratories Debt to Equity Ratio https://ycharts.com/companies/ABT/debt_equity_ratio#:~:text=Abbott %20Laboratories%20Debt%20to%20Equity%20Ratio%3A %200.3803%20for%20Dec,31%2C%202023